The global in vitro fertilization market size accounted for USD 29.53 billion in 2024 and is expected to exceed around USD 69.27 billion by 2034, growing at a CAGR of 8.90% from 2024 to 2034.
The in vitro fertilization market involves a medical procedure to treat infertility in which an egg is combined with a sperm in vitro, i.e., in a laboratory. The increasing incidences of infertility in both males and females potentiate the use of in vitro fertilization technique. Infertility is caused due to age or other chronic health conditions. In vitro fertilization (IVF) involves fertilization, embryo development, and implantation. Favorable government support and suitable regulatory frameworks drive the market. Several government and private organizations are at the forefront of increasing awareness about IVF techniques. Additionally, the availability of funds and favorable reimbursement policies boost market growth.
Industry Worth | Details |
Market Size in 2024 | USD 29.53 Billion |
Market Size in 2025 | USD 32.16 Billion |
Market Size by 2034 | USD 69.27 Billion |
Market Growth Rate from 2025 to 2034 | CAGR of 8.9% |
The future of the in vitro fertilization market looks promising, driven by technological advancements and socio-demographic trends. Advanced technologies favor automation and miniaturization of the IVF laboratory. The growing demand for microfluidics and lab-on-a-chip devices presents future growth opportunities. This reduces reagent consumption, decreases labor intensity, facilitates ease of use, and offers medium to high throughput. Leveraging artificial intelligence in IVF may aid in selecting the best oocyte and sperm combination, thereby predicting embryo quality.
Published by Kesiya Chacko
Subsegment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
---|---|---|---|---|---|---|---|---|---|---|---|
Equipment | - | - | - | - | - | - | - | - | - | - | - |
Reagents and Media | - | - | - | - | - | - | - | - | - | - | - |
Accessories | - | - | - | - | - | - | - | - | - | - | - |
Subsegment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
---|---|---|---|---|---|---|---|---|---|---|---|
Fresh Non-donor Cycle | - | - | - | - | - | - | - | - | - | - | - |
Frozen Non-donor IVF Cycle | - | - | - | - | - | - | - | - | - | - | - |
Frozen Donor IVF Cycle | - | - | - | - | - | - | - | - | - | - | - |
Fresh Donor IVF Cycle | - | - | - | - | - | - | - | - | - | - | - |
Subsegment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
---|---|---|---|---|---|---|---|---|---|---|---|
Fertility Clinics | - | - | - | - | - | - | - | - | - | - | - |
Hospitals & Surgical Centers | - | - | - | - | - | - | - | - | - | - | - |
Cryobank and Research Institutes | - | - | - | - | - | - | - | - | - | - | - |
Subsegment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
---|---|---|---|---|---|---|---|---|---|---|---|
Conventional IVF | - | - | - | - | - | - | - | - | - | - | - |
IVF with ICSI | - | - | - | - | - | - | - | - | - | - | - |
IVF with Donor Eggs | - | - | - | - | - | - | - | - | - | - | - |
Subsegment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
---|---|---|---|---|---|---|---|---|---|---|---|
Equipment | - | - | - | - | - | - | - | - | - | - | - |
Reagents and Media | - | - | - | - | - | - | - | - | - | - | - |
Accessories | - | - | - | - | - | - | - | - | - | - | - |
Subsegment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
---|---|---|---|---|---|---|---|---|---|---|---|
Fresh Non-donor Cycle | - | - | - | - | - | - | - | - | - | - | - |
Frozen Non-donor IVF Cycle | - | - | - | - | - | - | - | - | - | - | - |
Frozen Donor IVF Cycle | - | - | - | - | - | - | - | - | - | - | - |
Fresh Donor IVF Cycle | - | - | - | - | - | - | - | - | - | - | - |
Subsegment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
---|---|---|---|---|---|---|---|---|---|---|---|
Fertility Clinics | - | - | - | - | - | - | - | - | - | - | - |
Hospitals & Surgical Centers | - | - | - | - | - | - | - | - | - | - | - |
Cryobank and Research Institutes | - | - | - | - | - | - | - | - | - | - | - |
Subsegment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
---|---|---|---|---|---|---|---|---|---|---|---|
Conventional IVF | - | - | - | - | - | - | - | - | - | - | - |
IVF with ICSI | - | - | - | - | - | - | - | - | - | - | - |
IVF with Donor Eggs | - | - | - | - | - | - | - | - | - | - | - |
Subsegment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
---|---|---|---|---|---|---|---|---|---|---|---|
Equipment | - | - | - | - | - | - | - | - | - | - | - |
Reagents and Media | - | - | - | - | - | - | - | - | - | - | - |
Accessories | - | - | - | - | - | - | - | - | - | - | - |
Subsegment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
---|---|---|---|---|---|---|---|---|---|---|---|
Fresh Non-donor Cycle | - | - | - | - | - | - | - | - | - | - | - |
Frozen Non-donor IVF Cycle | - | - | - | - | - | - | - | - | - | - | - |
Frozen Donor IVF Cycle | - | - | - | - | - | - | - | - | - | - | - |
Fresh Donor IVF Cycle | - | - | - | - | - | - | - | - | - | - | - |
Subsegment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
---|---|---|---|---|---|---|---|---|---|---|---|
Fresh Donor | - | - | - | - | - | - | - | - | - | - | - |
Fresh Non-Donor | - | - | - | - | - | - | - | - | - | - | - |
Frozen Donor | - | - | - | - | - | - | - | - | - | - | - |
Frozen Non-Donor | - | - | - | - | - | - | - | - | - | - | - |
Subsegment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
---|---|---|---|---|---|---|---|---|---|---|---|
Fertility Clinics | - | - | - | - | - | - | - | - | - | - | - |
Surgical Centers | - | - | - | - | - | - | - | - | - | - | - |
Hospitals | - | - | - | - | - | - | - | - | - | - | - |
Research Institutes | - | - | - | - | - | - | - | - | - | - | - |
Subsegment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
---|---|---|---|---|---|---|---|---|---|---|---|
Equipment | - | - | - | - | - | - | - | - | - | - | - |
Reagents & Media | - | - | - | - | - | - | - | - | - | - | - |
Accessories | - | - | - | - | - | - | - | - | - | - | - |
Subsegment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
---|---|---|---|---|---|---|---|---|---|---|---|
Conventional IVF | - | - | - | - | - | - | - | - | - | - | - |
IVF with ICSI | - | - | - | - | - | - | - | - | - | - | - |
IVF with Donar Eggs | - | - | - | - | - | - | - | - | - | - | - |
Others | - | - | - | - | - | - | - | - | - | - | - |
Subsegment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
---|---|---|---|---|---|---|---|---|---|---|---|
Culture Media | - | - | - | - | - | - | - | - | - | - | - |
Disposable Devices | - | - | - | - | - | - | - | - | - | - | - |
Capital Equipment | - | - | - | - | - | - | - | - | - | - | - |
To get full access to our Market Insights, you need a Professional Account or a Business Suite.
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Our customers work more efficiently and benefit from